News

News
JNJ Press releases

Experts Say Houston Offers Medical Device Startups a Place to Thrive

Read full story
Partner news

On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC)

Read full story
JNJ Press releases

What’s Brewing at JLINX?

Read full story
Partner news

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Read full story
Partner news

Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Read full story
JNJ Press releases

Johnson & Johnson Innovation announces winners of the Singapore QuickFire Challenge in collaboration with ETPL and SMART

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches Seoul Innovation QuickFire Challenge in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
In the media

Exec Chat: JNJ's Innovation Partnering Strategy Goes Broad And Beyond 'Pinpoint Intervention'

Read full story
JNJ Press releases

Bavarian Nordic Announces Agreement with Janssen for the Development of Vaccine Regimens against HIV-1 and Hepatitis B

Read full story
Partner news

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Read full story
Partner news

BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder

Read full story
In the media

Breaking down barriers – the best way to positively impact everybody’s health

Read full story
In the media

Breaking down barriers – the best way to positively impact everybody’s health

Read full story
Partner news

E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline

Read full story
Partner news

Provention Bio, Inc. Appoints Eleanor L. Ramos, MD, as Chief Medical Officer and Chief Operating Officer

Read full story